Amaury Daste
Université de Bordeaux(FR)Centre Hospitalier Universitaire de Bordeaux(FR)Hôpital Saint-André(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study(2020)360 cited
- → Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC(2018)306 cited
- → Immune checkpoint inhibitors and elderly people: A review(2017)196 cited
- → Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck(2019)180 cited
- → Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651(2022)145 cited
- → A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study(2017)